Apoptosis; asthma and airways disease; anticoagulants; bowel cancer; liver disease; cardiovascular disease, especially atherosclerotic and cardiac failure as well as hypertension; clinical and public health nutrition; cytotoxic lymphocytes; diabetes; gene regulation; haemostasis; oncology; inflammatory disease (joints, skin and kidneys); infectious diseases; intensive care medicine; intracellular signalling; movement disorders; osteoporosis; osteoarthritis; peptic ulcer; proteases and protease inhibitors; platelet biology; renal disease; reproductive medicine; serine proteinase inhibitors; skin cancer; psoriasis; clinical pharmacology; gerontology; palliative care; neurodegenerative diseases including alzheimer's disease; neuro-otology; clinical and basic research in the cardiology, vascular and respiratory areas including vascular biology, physiology and pharmacology of the peripheral and coronary vasculature; metabolic vasodilation; vascular effects of hormone replacement, vitamin therapy, hypercholesterolaemia and diabetes; pathophysiology of left atrial thrombus; mitral stenosis; atrial fibrillation; pulmonary circulation; pulmonary hypertension; cardiac function, coagulation activity; acute coronary syndromes; inotropic agents; asthma; bronchiectasis; sleep disorders; thrombosis; platelets; Von Willebrand factor; fibrinogen; intracellular signalling; glycoprotein [alpha]IIb[beta]3, RhoA, actin cytoskeleton, haemopoiesis; serpins; yeast-2-hybrid; fibrinolysis; tissue plasminogen activator; urokinase plasminogen activator; plasminogen activator inhibitor-2.
Previous page | Next page | Section contents | Title and contents